Showing results (1-10 of 138) with videos related to
Sort By:
Pageof 14
International Reviews of Immunology|July 5, 2006
Adjuvant activity of CpG oligodeoxynucleotidesDennis M KlinmanExpert Review of Vaccines|July 11, 2006
CpG oligonucleotides accelerate and boost the immune response elicited by AVA, the licensed anthrax vaccineDennis M KlinmanExpert Opinion on Biological Therapy|June 4, 2004
Use of CpG oligodeoxynucleotides as immunoprotective agentsDennis M KlinmanClinical Immunology (Orlando, Fla.)|October 31, 2003
Immunoregulatory activity of CpG oligonucleotides in humans and nonhuman primatesDaniela Verthelyi, Dennis M KlinmanCancer Immunology, Immunotherapy : CII|February 15, 2011
CpG-conjugated apoptotic tumor cells elicit potent tumor-specific immunityHidekazu Shirota, Dennis M KlinmanVaccine|April 30, 2009
A single-dose combination therapy that both prevents and treats anthrax infectionDennis M Klinman, Debra TrossExpert Review of Vaccines|December 7, 2013
Recent progress concerning CpG DNA and its use as a vaccine adjuvantHidekazu Shirota, Dennis M KlinmanJournal of Thoracic Disease|October 18, 2016
Suppressive oligonucleotides inhibit inflammation in a murine model of mechanical ventilator induced lung injuryJulia Scheiermann, Dennis M KlinmanOncoimmunology|August 31, 2012
Effect of CpG ODN on monocytic myeloid derived suppressor cellsHidekazu Shirota, Dennis M KlinmanPageof 14